H.C. Wainwright Starts Talphera (TLPH) at Buy Jun 5, 2026 06:50AM
Talphera (TLPH) Misses Q1 EPS by 4c May 13, 2026 04:20PM
WestPark Capital Starts Talphera (TLPH) at Buy Apr 30, 2026 12:27PM
Talphera (TLPH) Misses Q4 EPS by 6c Mar 23, 2026 09:07PM
Talphera reaches 50% enrollment in NEPHRO-CRRT registrational trial Mar 2, 2026 08:31AM


Aug 25, 2025 08:31AM Talphera reaches 17-patient enrollment in NEPHRO CRRT pivotal trial
Apr 1, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Talphera (TLPH)
Mar 31, 2025 08:30AM Talphera (TLPH) Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement
Jan 28, 2025 06:43AM Rodman & Renshaw Starts Talphera (TLPH) at Buy
Jan 14, 2025 08:35AM Talphera (TLPH) Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study
Aug 19, 2024 08:32AM Talphera (TLPH) Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit